Introducing DCODE (Disease Cost Outcomes Data Environment): Vision4Health’s purpose-built, proprietary tool to inform your market access strategy and enhance the smoother adoption of your product in the UK.
The UK’s health system is evolving rapidly. With the recent announcement on the abolition of NHS England and the variation in local regions, market access is not a one-size-fits-all process. With the new government laying out the ‘three shifts’ for the health system – from analogue to digital; from hospitals to community; from treating sickness to prevention – a new life sciences strategy on the horizon and continued uncertainty around VPAG, there is even more of a need for granular local planning.
DCODE is specifically designed for local access in a complex and fragmented UK health system and is an efficient method to bring you alignment and consistency, and identify gaps in your UK market access approach. Through a series of insight-led questions and a unique weighted scoring system it provides an assessment of products that are pre-launch or already on the market but experiencing local access challenges. By focusing on regional relevance, real-world evidence, and practical outcomes, DCODE enables life sciences companies to:
- Build smarter business cases
- Target resources more effectively and efficiently
- Demonstrate value where it matters most – on the ground, with patients
In the June issue of Pharmaceutical Marketing Europe (PME) you can read more about how the DCODE tool works to inform your market access strategy and build your value proposition for local adoption.
Whether you’re launching a novel therapeutic or a HealthTech product, if you want to learn more about DCODE and how it can help you, please don’t hesitate to contact us.
